Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases by Elizabeth R Volkmann, Oliver Distler, Martin Aringer, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Helmut Prosch

Get full text

Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis by Ilayda Gunes, Elana J. Bernstein, Shawn E. Cowper, Gauri Panse, Niki Pradhan, Lucy Duran Camacho, Nicolas Page, Elizabeth Bundschuh, Alyssa Williams, Mary Carns, Kathleen Aren, Sarah Fantus, Elizabeth R. Volkmann, Heather Bukiri, Chase Correia, Vijaya B. Kolachalama, F. Perry Wilson, Seamus Mawe, J. Matthew Mahoney, Monique Hinchcliff

Get full text

Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseTake-Home Points by Angela Kaczorowski-Worthley, BSN, Dinesh Pal Mudaranthakam, PhD, MBA, MS, Janell Reichuber, APRN, Chris Streiler, MD, Sahil Pandya, MD, Ryan Boente, MD, Susan K. Mathai, MD, Ayodeji Adegunsoye, MD, Jeff Swigris, DO, MS, Elizabeth R. Volkmann, MD, MS, Joshua J. Solomon, MD, Bryant R. England, MD, PhD, Scott M. Matson, MD

Get full text